HMGB1 and cancer: High Mobility Group Box 1 (HMGB1), released by necrotic and activated immune cells, triggers NETosis via TLR4, RAGE, and MAPK signaling, and in cancer settings, also engages RIPK1-TNF signaling to couple NETs with tumor progression [54, 57, 58].